Lipophilicity of vinpocetine and related compounds characterized by reversed-phase thin-layer chromatography

Journal of Chromatography A

Volumn 996, Issue 1-2, 2003, Pages 195-203

  Mazák, Károly ^a   Vámos, József ^a   Nemes, András ^b   Rácz, Ákos ^a   Noszál, Béla ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b GEDEON RICHTER LTD   (Hungary)

Author keywords

Alkaloids; Apovincaminic acid; Lipophilicity; Partition coefficients; Vincamine; Vinpocetine

Indexed keywords

HYDROPHILICITY; ORGANIC SOLVENTS; SOLUBILITY; STRUCTURE (COMPOSITION);

LIPOPHILICITY;

THIN LAYER CHROMATOGRAPHY;

(2 ACETOXY)ETHYL APOVINCAMINATE; (2 HYDROXY)ETHYL APOVINCAMINATE; (3 ACETOXY)PROPYL APOVINCAMINATE; (3 HYDROXY)PROPYL APOVINCAMINATE; 2,3 DIMETHYLPYRIDO[1,2 A]PYRIMIDINE; 3 BENZYL 2 METHYLPYRIDO[1,2 A]PYRIMIDINE; 3 ETHYL 2 METHYLPYRIDO[1,2 A]PYRIMIDINE; 3 ETHYL 6 METHYLPYRIDO[1,2 A]PYRIMIDINE; 6 METHYL 3 PHENYLPYRIDO[1,2 A]PYRIMIDINE; APOVINCAMINIC ACID; CHLORPROMAZINE; PROGESTERONE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG; VINCAMINE; VINPOCETINE;

ARTICLE; CALIBRATION; HYDROPHILICITY; LIPOPHILICITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 0037683420     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9673(03)00617-4     Document Type: Article

References (32)

1. 1st Log P Symposium, Lipophilicity in Drug Research and Toxicology, Lausanne:1995.
2. 2nd Log P Symposium, Lipophilicity in Drug Disposition, Lausanne:2000.
3. Comer J., Tam K. Testa B., van de Waterbeemd H., Folkers G., Guy R. Pharmacokinetic Optimization in Drug Research. 2001;275 Wiley-VCH, Zurich.
4. Valkó K., Bevan C., Reynolds D. Anal. Chem. 69:1997;2022.
5. Hansch C. Wermuth C.G., Koga N., König H. Medicinal Chemistry for the 21st Century. 1994;281 Metcalf Blackwell, Oxford.
6. Pagliara A., Carrupt P.A., Caron G., Gaillard P., Testa B. Chem. Rev. 97:1997;3385.
7. Weinshaar R.E., Bristol J.A. Hansch C. Comprehensive Medicinal Chemistry. Vol. 2:1990;Pergamon Press, Oxford.
8. Rischke R., Krieglstein J. Pharmacology. 41:1990;153.
9. Czibula L., Nemes A., Visky Gy., Farkas M., Szombathelyi Zs., Kárpáti E., Sohár P., Kessel M., Kreidl J. Liebigs Ann. Chem. 3:1993;221.
10. Cs. Szántay, M. Moldvai, A. Vedres, M. Incze, J. Kreidl, L. Czibula, J. Farkas, I. Juhász, A. Gere, M. Paróczai, E. Lapis, A. Szekeres, M. Balázs Zajer, Á. Sarkadi, F. Auth, B. Kiss, E. Kárpáti, S. Farkas, to Gedeon Richter Ltd., Preparation of trans-Apovincaminic Acid Ester Derivatives as Neurological Drugs, PCT Int. Appl. WO 9 723 481, 3 July 1997; Chem. Abstr., 127 (1998) 135982.
11. Mazák K., Nemes A., Noszál B. Pharm. Res. 16:1999;1757.
12. Pudleiner P., Vereczkey L. Eur. J. Drug Metab. Pharmacokinet. 18:1993;317.
13. Kobayashi D., Matsuzawa T., Sugibayashi K., Morimoto Y., Kobayashi M., Kimura M. Biol. Pharm. Bull. 16:(3):1993;254.
14. Polgár M., Vereczkey L., Nyári L. J. Pharm. Biomed. Anal. 3:1985;131.
15. Biagi G.L., Barbaro A.M., Sapone A., Recantini M. J. Chromatogr. A. 662:1994;341.
16. van de Waterbeemd H., Mannhold R. Pliska V., Testa B., van de Waterbeems H. Lipophilicity in Drug Action And Toxicology. 1996;401 VCH, Weinheim.
17. Almási J., Takács-Novák K., Kökösi J., Vámos J. Int. J. Pharm. 180:1999;13.
18. Takács-Novák K., Perjési P., Vámos J. J. Planar Chromatogr. 14:2001;42.
19. Sawik T., Kowalski C. J. Chromatogr. A. 952:2002;295.
20. Biagi G.L., Barbaro A.M., Recantini M. J. Chromatogr. A. 678:1994;127.
21. Niewiadomy A., Zabinska A., Matysiak J., Rozylo J.K. J. Chromatogr. A. 791:1997;237.
22. Cimpan G., Hadaruga M., Miclaus V. J. Chromatogr. A. 869:2000;49.
23. Hulshoff A., Perrin J.H. J. Chromatogr. 120:1976;65.
24. Vámos J., Kökösi J., Szász Gy., Hankó-Novák K., Józan M., Kapolka P. Acta Pharm. Hung. 58:1988;247.
25. I. Hermecz, Z. Mészáros, in: A.R. Katriczky (Ed.), Advances in Heterocyclic Chemistry, Vol. 33, Academic Press, New York, 1983.
26. Takács-Novák K., Szász Gy. Pharm. Res. 16:1999;1633.
27. Reymond F., Gobry V., Bouchard G., Girault H. Testa B., van de Waterbeemd H., Folkers G., Guy R. Pharmacokinetic Optimization in Drug Research. 2001;327 Wiley-VCH, Zurich.
28. Bouchard G., Carrupt P.A., Testa B., Gobry V., Girault H.H. Pharm. Res. 18:2001;702.
29. Noszál B., Kraszni M. J. Phys. Chem. B. 106:2002;1066.
30. Szántay Cs., Nemes A. Saxton J.E. The Monoterpenoid Indole Alkaloids. 1994;437 Wiley.
31. Fitos I., Visy J., Simonyi M. Biochem. Pharmacol. 41:1991;377.
32. Ashwood V.A., Field M.J., Horwell D.C., Julien-Larose C., Lewthwaite R.A., McCleary S., Pritchard M.C., Raphy J., Singh L. J. Med. Chem. 44:2001;2276.